	ODT version	34.279378715521695
¡°	vardenafil ODT limitation	27.406353693520956
	sorbitol	26.63398384700028
	ED ODT drug	21.249588964599834
¡°	vardenafil hydrochloride	20.60961229047492
	odt	18.584386903542956
	a. Vardenafil ODT Limitation	17.812313488712338
	mannitol	16.621891439728774
	immediate release ODT formulation	14.074625280357022
	ODT formulation immediate release	11.72885440029752
¡°	Levitra	4.497613620441349
	Boolell	4.497613620441349
	Other Approved ED Drugs	4.198475382820883
	approve ED drug	4.123800567830274
	sildenafil formulation	4.018118383438582
	Fryburg	3.7496692756449836
	erectile disfunction ED drug	3.6163577333759256
	Viagra	3.001063325857648
	erectile dysfunction drug	2.831289355272387
	sugar alcohols3	2.3188128667944223
	Staxyn	2.251794599578464
	erectile dysfunction medication	2.1001173363808836
	expect bitter taste	2.0444196274434896
	approach	1.7664017697538787
	discussion	1.7663243188831699
	argument	1.7656407769510556
	Cialis	1.5018619221922411
	Furitsu application	1.4978812570885514
	Habib reference	1.2498921348212544
	two phosphodiesterase inhibitor	1.0530432826738365
	Fu reference	1.0003568182254756
	Chang listing	0.9793579398893778
	least two sugar alcohol	0.9250897281907333
	least one sugar alcohol	0.9250897065170051
	Chang disclosure	0.903306125394809
	excipient	0.887485828061364
	trihydrate	0.8663136659654787
	post trial briefing identifie	0.7855001047662802
¡°	vardenafil2	0.7512641159584247
	Lavipharm	0.7512641159584247
	fryburg	0.7512641159584247
	SCRIP reference	0.7506005761324145
	Chang reference state	0.677289343543741
	Fast Dissolve Dosage form	0.6635442366654362
	pfizer	0.5968463682706882
	oral disintegrating tablet	0.5374534657353583
	fast dissolving tablet	0.5260377413655778
	Oral Cavity	0.5219056494687074
	immediate release tablet	0.47865299194353805
	Prior Art suggest Formulating Vardenafil	0.4321288814831365
	uncoated tablet	0.41597042213595237
	Bayer1 approval	0.40734481110524695
	Bell Huff application	0.3886632310337595
	immediate release formulation	0.3648078415610402
	increase bioavailability	0.35845841175225146
	Chen international application	0.28405872506850904
	drug formulation	0.26667455508650467
	fast dissolve tablet	0.25616743926018065
	immediate release limitation	0.2541263995272154
	expert	0.23210244636932517
	Pfizer	0.19122612497823865
	objective evidence	0.17490465537749653
	good candidate	0.166939307543209
	J.A.	0.1430050525035556
	Kubin	0.12542828201565748
	fast disperse fast dissolve dosage form	0.10895587713549376
	Eisai	0.10709676400029972
	five drug class	0.0921206870913462
	priority	0.04018068355441739
	ed medication	0.03704665612003878
	FDA	0.03700551517560339
	motivation	0.03692279366409706
	nine reference	0.03323123187787492
	multiple exemplary reference	0.028465997130879953
	plan	0.027032028073752053
	nine prior art reference	0.02492213064265888
	Delaware	0.024515269798088088
	skilled artisan	0.023387777176601485
	Moore	0.021390141121180303
	Eli Lilly	0.01603014062301614
	oral dosage form	0.015572111259161666
	Abbreviated New Drug Application	0.014011688692897244
	Food Drug Administration	0.012609088171508475
	nonobviousness	0.01174398623632034
	market	0.010982340275232667
	definite firm conviction	0.00809836159646143
	Apotex	0.0079527882175879
	numerous company	0.007372273110382759
	ANDA	0.006545522536251307
	Obviousness	0.004124910622994832
	generic version	0.004111161105540982
	counterclaim	0.0040534324203945924
	protection	0.003748691394246954
	doubt	0.003111454729905133
	six reference	0.003047363145403995
	March	0.0030472989694165513
	assignee	0.0026624461362636234
	instant case	0.0026509335596390255
	key reference	0.0025645035709067772
	six day bench trial	0.0024304247563981126
	simple point	0.0023071020055548228
	one company	0.0019597889000255012
	key prior art	0.0019203022077379569
	numerous prior art reference	0.001728855062498943
	May	0.0016835010740108532
	following factual determination	0.0016758940204806697
	underlying factual finding	0.0015947533613721188
	five type	0.0015660647372373957
	trial exhibit	0.0014128426708780743
	December	0.0012510577216914172
	express disclosure	0.0009738872607510536
	entire evidence	0.0005950602585619697
	commercial embodiment	0.0005457757838074053
	testimony	0.0004724810333758738
	content	0.0004198288187982848
	assertion	0.00036300916759419765
	clear convincing evidence	0.0003410951467598423
	significant number	0.0002867971843681335
	ordinary skill	0.00023612446163700647
	burden	0.00016303805673188826
	narrow point	0.0001374161864038367
	final judgment	9.062316452008015e-05
	obviousness ground	8.611032614682617e-05
	one example	7.616347346066199e-05
	de novo	7.554581249121197e-05
	holding	7.406324866737865e-05
	background	7.20829226475016e-05
	requirement	6.570121305443618e-05
	various reference	3.435157582879447e-05
	jurisdiction	3.05705125090828e-05
	fact finding	1.8492337360487458e-05
	difference	1.1453201061977084e-05
	district court finding	1.1097508224589377e-05
	first three reference	9.781044998897329e-06
	three application	8.70350595280953e-06
	district court clear error	7.4458307969495835e-06
	set	7.3803561268525395e-06
	element	6.3665995133183366e-06
	relevant prior art	3.847288344695965e-06
	time	3.7672269835365067e-06
	light	3.7074400965724736e-06
	subject matter	2.0467630190272074e-06
	patentee	1.7878598543173414e-06
	conclusion	1.5296098314260897e-06
	district court decision	1.1971633412924234e-06
	scope	4.479525907506423e-07
	action	2.186843698453213e-07
	party	1.1506544864469695e-07
	district court fact	1.4263264475602556e-08
	review court	8.182244723740304e-09
	invention	1.9366403970870712e-09
	issue	9.905372847011098e-10
	District	0.0
	Court	0.0
	Appeals	0.0
	Inc.	0.0
	Fed	0.0
